Bristol-Myers Squibb unveiled the Orencia ClickJect autoinjector, which is designed for self-administration of Orencia to treat moderate to severe rheumatoid…

A new tissue chip made from a silk gel forms a scaffold that matches a target tissue and gives researchers a window into biological processes. What’s more, the…

Researchers at Texas A&M University have developed a nano-sized delivery system that could help bring injected treatments such as insulin into the oral…

Enteris BioPharma, a privately held API company, launched a clinical program for its oral tablet formulation of Tobrate (tobramycin) designed to be used for…

Woburn, MA-based Aphios said it landed a subcontract for the nanoformulation of a new superhydrophobic anticancer drug called Brefeldin A.

Amgen said the FDA has approved its Repatha (evolocumab) Pushtronex system, the first hands-free, once-monthly delivery option for a PCSK9 inhibitor.

The New Jersey Institute of Technology received a $1 million grant from the W. M. Keck Foundation it will use to study new materials for nanotechnology.

Aptuit, a drug discovery and development CRO, has signed a deal with gene therapy player Dimension Therapeutics to support studies for select rare disease…

Researchers at Memorial Sloan Kettering have uncovered a new way to target drugs specifically to cancer sites in the body, including metastatic tumors.